FLGT

$0.00

(

0.00%

)
Quote details

stock

Fulgent Genetics Inc

NASDAQ | FLGT

23.36

USD

$0.00

(

0.00%

)

At Close (As of Oct 23, 2025)

$733.70M

Market Cap

-

P/E Ratio

-1.66

EPS

$24.64

52 Week High

$14.57

52 Week Low

HEALTHCARE

Sector

FLGT Chart

Recent Chart
Price Action

FLGT Technicals

Tags:

FLGT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $107M
Total Revenue $283M
Cost Of Revenue $176M
Costof Goods And Services Sold $176M
Operating Income -$74M
Selling General And Administrative $88M
Research And Development $49M
Operating Expenses $181M
Investment Income Net -
Net Interest Income $31M
Interest Income $31M
Interest Expense $170K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $25M
Income Before Tax -$52M
Income Tax Expense -$8.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$44M
Comprehensive Income Net Of Tax -
Ebit -$74M
Ebitda -$49M
Net Income -$43M

Revenue & Profitability

Earnings Performance

FLGT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.2B
Total Current Assets $354M
Cash And Cash Equivalents At Carrying Value $55M
Cash And Short Term Investments $55M
Inventory $8.4M
Current Net Receivables $69M
Total Non Current Assets $866M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $135M
Intangible Assets Excluding Goodwill $135M
Goodwill $22M
Investments -
Long Term Investments $570M
Short Term Investments $203M
Other Current Assets $30M
Other Non Current Assets -
Total Liabilities $91M
Total Current Liabilities $73M
Current Accounts Payable $18M
Deferred Revenue -
Current Debt -
Short Term Debt $412K
Total Non Current Liabilities $18M
Capital Lease Obligations $5.6M
Long Term Debt $2.5M
Current Long Term Debt $412K
Long Term Debt Noncurrent -
Short Long Term Debt Total $9.2M
Other Current Liabilities $24M
Other Non Current Liabilities $4.9M
Total Shareholder Equity $1.1B
Treasury Stock -
Retained Earnings $590M
Common Stock $3K
Common Stock Shares Outstanding $30M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $21M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $25M
Capital Expenditures $40M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$58M
Cashflow From Financing -$4.8M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$3.1M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$44M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $107M
Total Revenue $283M
Cost Of Revenue $176M
Costof Goods And Services Sold $176M
Operating Income -$74M
Selling General And Administrative $88M
Research And Development $49M
Operating Expenses $181M
Investment Income Net -
Net Interest Income $31M
Interest Income $31M
Interest Expense $170K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $25M
Income Before Tax -$52M
Income Tax Expense -$8.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$44M
Comprehensive Income Net Of Tax -
Ebit -$74M
Ebitda -$49M
Net Income -$43M

FLGT News

FLGT Profile

Fulgent Genetics Inc Profile

Sector: HEALTHCARE

Industry: DIAGNOSTICS & RESEARCH

Fulgent Genetics, Inc. is a leading provider of advanced genetic testing and diagnostic solutions, headquartered in Temple City, California. The company utilizes innovative technology to offer a wide range of testing services, including comprehensive genomics and COVID-19 diagnostics, aimed at delivering clinically actionable insights for healthcare providers. Fulgent's commitment to precision and innovation positions it as a key player in the rapidly advancing fields of genetic medicine and public health, poised for continued growth in an ever-evolving market.

BYND
-1.10%
$3.58
YDKG
+14.70%
$0.07
YYAI
-46.43%
$0.10
VHAI
0.00%
$0.00
SCNX
+125.72%
$1.29
CGBS
-39.47%
$0.03
BITF
-12.24%
$3.94
WTO
+10.81%
$0.07
TLRY
-2.02%
$1.45
VTYX
+82.90%
$7.06
AXDX
-61.36%
$0.03
AMD
-3.27%
$230.23
RGTI
+14.70%
$41.36
AAL
-2.10%
$12.09
PLTR
-3.31%
$175.49
NVTS
-9.48%
$13.60
NIO
+0.58%
$6.84
HPE
-0.77%
$23.09
AREB
+37.20%
$2.95
ADAP
+7.31%
$0.07
NOK
+10.09%
$6.11
F
-1.08%
$12.29
RR
-10.12%
$5.05
QBTS
+19.10%
$32.50
RIVN
-2.12%
$12.92
MARA
-4.58%
$19.14
TSLA
-3.61%
$423.08
RMBL
+60.50%
$3.21
IONZ
-18.13%
$3.81
ADD
-25.47%
$0.05
DVLT
-15.41%
$2.14
GOOGL
+0.49%
$251.69
BAC
-0.81%
$51.10
SRM
+53.27%
$10.30
RBNE
+28.34%
$1.63
BURU
-6.30%
$0.33
SGBX
+40.78%
$3.21
PBR
+1.47%
$11.73
VIVK
+7.79%
$0.24
NDLS
+33.01%
$0.95
CUTR
-10.19%
$0.09
WLGS
-5.57%
$0.04
IONQ
+12.66%
$62.47
ETWO
0.00%
$3.30
ITUB
+0.56%
$7.07
AFMD
-34.94%
$0.18
PLUG
+0.64%
$2.93
BTE
+2.71%
$2.27
TNGX
-5.08%
$8.22
MU
-1.88%
$198.47
NEHC
-12.47%
$3.79
IBIO
-2.87%
$1.35
RGTZ
-25.52%
$13.92
OPI
-16.97%
$0.20
KLG
-9.05%
$13.35
QUBT
+9.34%
$16.26
AG
-0.70%
$12.66
QS
+11.68%
$15.16
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
RIG
+3.90%
$3.55
SMCI
-5.80%
$49.45
LAES
+11.20%
$6.00
INTC
+0.20%
$36.99
DNN
+2.21%
$2.78
KDLY
-4.25%
$0.72
TSM
-1.91%
$288.88
CSCO
-0.08%
$70.66
SAND
-6.04%
$12.12
WWR
-15.84%
$1.54
SHOT
-74.37%
$0.39
NVDA
+0.20%
$180.65
SOFI
+1.59%
$27.62
TMQ
-7.19%
$5.16
ZAPP
-46.30%
$0.15
PSTV
-4.84%
$0.58
CAN
+7.03%
$1.82
NAYA
+17.48%
$0.63
IVF
+17.48%
$0.63
T
-2.44%
$24.92
PTEN
+0.82%
$6.08
IBRX
-3.27%
$2.36
IREN
+6.21%
$55.05
ON
-5.71%
$51.93
ELBM
+6.02%
$1.76
MRK
-0.01%
$87.61
GPUS
-3.89%
$0.37
CIFR
+2.88%
$16.57
EONR
+11.95%
$0.70
AIRE
+4.45%
$0.74
EPWK
-1.98%
$0.07
AA
-4.24%
$35.65
UUUU
+1.01%
$22.97
CRM
-2.57%
$256.64
RXRX
+1.02%
$5.80
TE
-8.25%
$4.11
BTBT
+0.55%
$3.60
CJET
-8.24%
$0.09
ONDS
+3.18%
$6.95
FL
-0.37%
$24.01
BYND
-1.10%
$3.58
YDKG
+14.70%
$0.07
YYAI
-46.43%
$0.10
VHAI
0.00%
$0.00
SCNX
+125.72%
$1.29
CGBS
-39.47%
$0.03
BITF
-12.24%
$3.94
WTO
+10.81%
$0.07
TLRY
-2.02%
$1.45
VTYX
+82.90%
$7.06
AXDX
-61.36%
$0.03
AMD
-3.27%
$230.23
RGTI
+14.70%
$41.36
AAL
-2.10%
$12.09
PLTR
-3.31%
$175.49
NVTS
-9.48%
$13.60
NIO
+0.58%
$6.84
HPE
-0.77%
$23.09
AREB
+37.20%
$2.95
ADAP
+7.31%
$0.07
NOK
+10.09%
$6.11
F
-1.08%
$12.29
RR
-10.12%
$5.05
QBTS
+19.10%
$32.50
RIVN
-2.12%
$12.92
MARA
-4.58%
$19.14
TSLA
-3.61%
$423.08
RMBL
+60.50%
$3.21
IONZ
-18.13%
$3.81
ADD
-25.47%
$0.05
DVLT
-15.41%
$2.14
GOOGL
+0.49%
$251.69
BAC
-0.81%
$51.10
SRM
+53.27%
$10.30
RBNE
+28.34%
$1.63
BURU
-6.30%
$0.33
SGBX
+40.78%
$3.21
PBR
+1.47%
$11.73
VIVK
+7.79%
$0.24
NDLS
+33.01%
$0.95
CUTR
-10.19%
$0.09
WLGS
-5.57%
$0.04
IONQ
+12.66%
$62.47
ETWO
0.00%
$3.30
ITUB
+0.56%
$7.07
AFMD
-34.94%
$0.18
PLUG
+0.64%
$2.93
BTE
+2.71%
$2.27
TNGX
-5.08%
$8.22
MU
-1.88%
$198.47
NEHC
-12.47%
$3.79
IBIO
-2.87%
$1.35
RGTZ
-25.52%
$13.92
OPI
-16.97%
$0.20
KLG
-9.05%
$13.35
QUBT
+9.34%
$16.26
AG
-0.70%
$12.66
QS
+11.68%
$15.16
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
RIG
+3.90%
$3.55
SMCI
-5.80%
$49.45
LAES
+11.20%
$6.00
INTC
+0.20%
$36.99
DNN
+2.21%
$2.78
KDLY
-4.25%
$0.72
TSM
-1.91%
$288.88
CSCO
-0.08%
$70.66
SAND
-6.04%
$12.12
WWR
-15.84%
$1.54
SHOT
-74.37%
$0.39
NVDA
+0.20%
$180.65
SOFI
+1.59%
$27.62
TMQ
-7.19%
$5.16
ZAPP
-46.30%
$0.15
PSTV
-4.84%
$0.58
CAN
+7.03%
$1.82
NAYA
+17.48%
$0.63
IVF
+17.48%
$0.63
T
-2.44%
$24.92
PTEN
+0.82%
$6.08
IBRX
-3.27%
$2.36
IREN
+6.21%
$55.05
ON
-5.71%
$51.93
ELBM
+6.02%
$1.76
MRK
-0.01%
$87.61
GPUS
-3.89%
$0.37
CIFR
+2.88%
$16.57
EONR
+11.95%
$0.70
AIRE
+4.45%
$0.74
EPWK
-1.98%
$0.07
AA
-4.24%
$35.65
UUUU
+1.01%
$22.97
CRM
-2.57%
$256.64
RXRX
+1.02%
$5.80
TE
-8.25%
$4.11
BTBT
+0.55%
$3.60
CJET
-8.24%
$0.09
ONDS
+3.18%
$6.95
FL
-0.37%
$24.01

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.